CN1767858A - 生物活性材料与生物适合聚合物中的羧基按1∶1的比例结合,包括制备方法及相同的药用成分 - Google Patents

生物活性材料与生物适合聚合物中的羧基按1∶1的比例结合,包括制备方法及相同的药用成分 Download PDF

Info

Publication number
CN1767858A
CN1767858A CNA2004800084834A CN200480008483A CN1767858A CN 1767858 A CN1767858 A CN 1767858A CN A2004800084834 A CNA2004800084834 A CN A2004800084834A CN 200480008483 A CN200480008483 A CN 200480008483A CN 1767858 A CN1767858 A CN 1767858A
Authority
CN
China
Prior art keywords
factor
bioactive materials
conjugate
biocompatible polymer
csf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800084834A
Other languages
English (en)
Chinese (zh)
Inventor
朴明玉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BiopolyMed Inc
Original Assignee
BiopolyMed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BiopolyMed Inc filed Critical BiopolyMed Inc
Publication of CN1767858A publication Critical patent/CN1767858A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
CNA2004800084834A 2003-03-28 2004-03-27 生物活性材料与生物适合聚合物中的羧基按1∶1的比例结合,包括制备方法及相同的药用成分 Pending CN1767858A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20030019734 2003-03-28
KR1020030019734 2003-03-28
KR1020040007983 2004-02-06

Publications (1)

Publication Number Publication Date
CN1767858A true CN1767858A (zh) 2006-05-03

Family

ID=36743278

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800084834A Pending CN1767858A (zh) 2003-03-28 2004-03-27 生物活性材料与生物适合聚合物中的羧基按1∶1的比例结合,包括制备方法及相同的药用成分

Country Status (2)

Country Link
KR (1) KR20040086521A (ko)
CN (1) CN1767858A (ko)

Also Published As

Publication number Publication date
KR20040086521A (ko) 2004-10-11

Similar Documents

Publication Publication Date Title
CN102145178B (zh) Peg化白介素15
CN1182870C (zh) 结合稳定的治疗剂组合物、传递和诊断制剂
CN1168495C (zh) 被修饰的肿瘤坏死因子
CN1141977C (zh) 改进的病毒疫苗
US20070117924A1 (en) Biologically active material conjugated with biocompatible polymer with 1:1 complex, preparation method thereof and pharmaceutical composition comprising the same
EP1090645B1 (en) Oral delivery of chemically modified proteins
CN1960766A (zh) 新的g－csf轭合物
CN1368877A (zh) 含有可水解的亲脂成分的两亲药物－低聚物结合物及其制备和使用方法
CN1638808A (zh) 蛋白质与修饰多糖的偶联
CN1856507A (zh) 抗体的稳定化方法和被稳定的溶液状抗体制剂
CN1434725A (zh) 两亲聚合物以及包含两亲聚合物的多肽结合物
Veronese et al. Protein PEGylation, basic science and biological applications
CN1533808A (zh) 治疗冠状病毒感染和sars的组合物与方法
CN100355786C (zh) 聚乙二醇修饰的胸腺肽1衍生物
TW201138831A (en) Modified granulocyte colony stimulating factor (G-CSF)
CN1767858A (zh) 生物活性材料与生物适合聚合物中的羧基按1∶1的比例结合,包括制备方法及相同的药用成分
CN101039696A (zh) 给药人il－18治疗创伤的方法
CN102807619B (zh) 含有免疫球蛋白Fc片段和粒细胞-巨噬细胞集落刺激因子的复合物及其药物组合物
US20050281778A1 (en) Human growth hormone conjugated with biocompatible polymer
TW200426155A (en) Activated polyethylene glycol esters
CN101062950B (zh) 聚乙二醇修饰的胸腺肽1衍生物
CN1871257A (zh) 干扰素－β复合物
CN103096916B (zh) 用于牛粒细胞集落刺激因子及其变体的制剂
CN1177053C (zh) 靶向性、高表达人粒细胞巨噬细胞集落刺激因子的重组腺病毒及其制法和用途
CN1569892A (zh) 多臂树杈型聚乙二醇与蛋白质或多肽的结合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060503